comparison of bone and renal effects in hiv-infected adults switching to abacavir or tenofovir based therapy in a randomized trial比较骨和肾功能的影响在感染艾滋病毒的成年人转向abacavir或替诺福韦治疗的随机试验.pdfVIP

comparison of bone and renal effects in hiv-infected adults switching to abacavir or tenofovir based therapy in a randomized trial比较骨和肾功能的影响在感染艾滋病毒的成年人转向abacavir或替诺福韦治疗的随机试验.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
comparison of bone and renal effects in hiv-infected adults switching to abacavir or tenofovir based therapy in a randomized trial比较骨和肾功能的影响在感染艾滋病毒的成年人转向abacavir或替诺福韦治疗的随机试验

Comparison of Bone and Renal Effects In HIV-infected Adults Switching to Abacavir or Tenofovir Based Therapy in a Randomized Trial 1 2 1 1 3 Thomas A. Rasmussen *, Danny Jensen , Martin Tolstrup , Ulla S. Nielsen , Erland J. Erlandsen , 2 1 4 1 Henrik Birn , Lars Østergaard , Bente L. Langdahl , Alex L. Laursen 1 Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark, 2 Department of Nephrology, Aarhus University Hospital and Institute of Biomedicine, Aarhus University, Aarhus, Denmark, 3 Department of Clinical Biochemistry, Viborg Regional Hospital, Viborg, Denmark, 4 Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark Abstract Introduction: Our objective was to compare the bone and renal effects among HIV-infected patients randomized to abacavir or tenofovir-based combination anti-retroviral therapy. Methods: In an open-label randomized trial, HIV-infected patients were randomized to switch from zidovudine/lamivudine (AZT/3TC) to abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC). We measured bone mass density (BMD) and bone turnover biomarkers (osteocalcin, osteocalcin, procollagen type 1 N-terminal propeptide (P1NP), alkaline phosphatase, type I collagen cross-linked C-telopeptide (CTx), and osteoprotegerin). We assessed renal function by estimated creatinine clearance, plasma cystatin C, and urinary levels of creatinine, albumin, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL). The changes from baseline in BMD and renal and bone biomarkers were c

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档